Potentiation by levamisole, methisoprinol, and adenine or adenosine of the inhibitory activity of human interferon against encephalomyocarditis virus.
AUTOR(ES)
Muñoz, A
RESUMO
The antiviral action of different human interferons against encephalomyocarditis virus in HeLa cell cultures was analyzed. Cell treatment with levamisole (200 micrograms/ml), methisoprinol (1 mg/ml), or adenine or adenosine (33 or 100 micrograms/ml, respectively) potentiated the anti-encephalomyocarditis virus activity of human interferon by 8- to 32-fold. A higher level of potentiation (256-fold) was achieved either by combined treatments with levamisole plus methisoprinol or by treatment with one of these compounds plus adenine or adenosine.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=176466Documentos Relacionados
- Activity of nitric oxide-generating compounds against encephalomyocarditis virus.
- Antiviral Activity of Limitin against Encephalomyocarditis Virus, Herpes Simplex Virus, and Mouse Hepatitis Virus: Diverse Requirements by Limitin and Alpha Interferon for Interferon Regulatory Factor 1
- Potentiation of interferon activity by mixed preparations of fibroblast and immune interferon.
- Adenine formation from adenosine by mycoplasmas: adenosine phosphorylase activity.
- Antiviral activity of bacteria-derived human alpha interferons against encephalomyocarditis virus infection of mice.
